レイヤード
TSE Standard ・ Ticker 634A ・ Upcoming
You can only enter this lottery through a broker underwriting it. The lead underwriter is SBI Securities, which receives the largest allocation.
Broker pages are in Japanese. A comparison in English is on the brokers page.
A medical DX company that provides SaaS for digitising clinic front-desk work in Japan, such as web-based pre-visit questionnaires and appointment booking.
It offers medical institutions several products that can be adopted one at a time, including the Symview web questionnaire, the Wakumy booking system, the Kakarite patient management tool and the Iver automated phone answering service, and earns monthly subscription fees plus a set-up fee charged at installation. It also sells advertising space on Medicastar, the digital signage it operates in waiting rooms, to pharmaceutical companies and others. About 6,000 medical institutions were using at least one of its products as of June 2026.
Its multi-product strategy is to have each clinic use more than one product and so lift revenue per site. Of the net proceeds from the offering, up to about 920 million yen, it plans to spend 200 million yen on extending existing products, 468 million yen on sales and customer support staff, and 250 million yen on publicity, investor relations and selling costs.
Read about this company in Japanese →Figures are taken from the offering documents and public sources, and are checked against two independent sources before publication. Nothing here is investment advice. Shares can and do open below their offer price.
